Supported by an educational grant from Axsome Therapeutics, Inc.

News

Pharmacogenomic Test Improves MDD Response and Remission Outcomes

Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with

All News

Dietary Intervention May Alleviate Symptoms of Depression

Adhering to specific dietary patterns, including the Mediterranean diet, may reduce symptoms of

Accelerated Theta-Burst Stimulation Protocol Improves Treatment-Resistant Depression

A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to resu

Genetic Predispositions to Insomnia, Neuroticism, Linked With Higher Risk for Treatment-Resistant Depression

A genetic predisposition to traits related to neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistan

Investigational MDD Drug Shows Favorable Outcome in Interim Analysis

An ongoing phase 2b trial investigating adjunctive ALTO-300 in patients with major depress